Anzeige
Mehr »
Login
Freitag, 10.01.2025 Börsentäglich über 12.000 News von 681 internationalen Medien
GameStop 2.0? ...alle Anzeichen für den nächsten großen Short Squeeze!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
48 Leser
Artikel bewerten:
(0)

Bank of South Carolina Corporation Announces Annual and Fourth Quarter Earnings

Finanznachrichten News

CHARLESTON, S.C., Jan. 9, 2025 /PRNewswire/ -- The Bank of South Carolina Corporation (OTCQX: BKSC) announced unaudited earnings of $6,749,736, or $1.24 and $1.23 basic and diluted earnings per share, respectively, for the year ended December 31, 2024 - an increase of $1,256,120, or 22.87%, from earnings for the year ended December 31, 2023 of $5,493,616, or $0.99 and $0.98 basic and diluted earnings per share, respectively. Unaudited earnings for the three months ended December 31, 2024 increased $454,530, or 33.33%, to $1,818,279 compared to $1,363,749 for the three months ended December 31, 2023. Returns on average assets and average equity for the year ended December 31, 2024 were 1.14% and 13.55%, respectively, compared with December 31, 2023 returns on average assets and average equity of 0.86% and 12.90%, respectively.

Eugene H. Walpole, IV, President and Chief Executive Officer, stated, "We are proud of our performance for both the quarter and year, in which we generated a return on average assets of 1.27% and 1.14%, respectively, and a return on average equity of 13.69% and 13.55%, respectively. Earnings of $6,749,736 in 2024 mark our second-best year to date. Increased noninterest income, consistent management of overhead, and a net interest margin that saw 85 basis points of improvement throughout the year spurred these favorable results. Meanwhile, loans outstanding grew more than 5% annually, while an ongoing focus on asset quality held non-performing assets to a minimum. The outlook for 2025 suggests another one or two rate cuts by the Federal Reserve are likely. Regardless of monetary policy, we will continue to carry out our strategy to deploy maturing investment securities into higher-yielding loans and other assets, which should further enhance net interest margin over time. Most importantly, I would like to thank our dedicated employees for their commitment to our bank and customers this past year."

Selected Condensed Consolidated Financial Data

(Unaudited)








For the Three Months Ended


December 31,
2024

September 30,
2024

June 30,
2024

March 31,
2024

December 31,
2023

Total Interest and Fee Income

$ 6,818,624

$ 6,848,831

$ 6,702,792

$ 6,593,463

$ 6,500,593

Total Interest Expense

1,406,681

1,566,695

1,564,362

1,861,311

1,821,435

Net Interest Income

5,411,943

5,282,136

5,138,430

4,732,152

4,679,158

Provision for Credit Losses

25,000

-

50,000

-

-

Net Interest Income After Provision for Credit Losses

5,386,943

5,282,136

5,088,430

4,732,152

4,679,158

Total Other Income

483,085

485,206

471,075

423,497

397,970

Total Other Expense

3,498,230

3,412,935

3,339,934

3,359,684

3,309,138

Income Before Income Tax Expense

2,371,798

2,354,407

2,219,571

1,795,965

1,767,988

Income Tax Expense

553,519

552,544

465,773

420,169

404,239

Net Income

$ 1,818,279

$ 1,801,863

$ 1,753,798

$ 1,375,796

$ 1,363,749













Earnings Per Share - Basic

$ 0.33

$ 0.33

$ 0.32

$ 0.25

$ 0.25

Earnings Per Share - Diluted

$ 0.33

$ 0.33

$ 0.32

$ 0.25

$ 0.24







Return on Average Assets

1.27 %

1.24 %

1.19 %

0.89 %

0.87 %

Return on Average Equity

13.69 %

14.04 %

14.71 %

11.69 %

12.74 %

Common Stock Shares Outstanding

5,432,762

5,445,519

5,457,907

5,462,794

5,469,251

Book Value Per Share

$ 9.63

$ 9.71

$ 8.93

$ 8.69

$ 8.61

Efficiency Ratio

59.34 %

59.18 %

59.54 %

65.17 %

65.18 %

Net Interest Margin

3.97 %

3.82 %

3.68 %

3.20 %

3.12 %

% Loans Past Due> 30 Days

0.25 %

0.16 %

0.19 %

0.32 %

0.53 %

Allowance for Credit Losses as a % of Total Loans

1.01 %

1.04 %

1.04 %

1.04 %

1.07 %







Quarterly Averages:






Total Assets

$ 569,812,437

$ 578,014,415

$ 590,639,502

$ 624,732,564

$ 625,093,859

Total Loans

$ 363,015,990

$ 358,623,795

$ 359,514,482

$ 353,396,331

$ 344,789,580

Total Deposits

$ 500,693,110

$ 512,024,560

$ 516,221,132

$ 519,023,338

$ 518,397,166

Total Shareholders' Equity

$ 52,837,535

$ 51,043,788

$ 47,951,482

$ 47,328,863

$ 42,464,898

About Bank of South Carolina Corporation
The Bank of South Carolina Corporation is the holding company of The Bank of South Carolina ("The Bank"). The Bank is a South Carolina state -chartered financial institution with offices in Charleston, North Charleston, Summerville, Mt. Pleasant, James Island, and the West Ashley community and has been in continuous operation since 1987. Our website is www.banksc.com. Bank of South Carolina Corporation currently trades its common stock on the OTCQX® Best Market under the symbol "BKSC".

Forward-Looking-Statements
This release contains forward-looking statements that are not historical facts and that are intended to be "forward-looking statements" as that term is defined by the Private Securities Litigation Reform Act of 1995. These forward-looking statements may include, but are not limited to, statements about the Company's plans, objectives, expectations and intentions and other statements contained in this release that are not historical facts and pertain to the Company's future operating results. When used in this release, the words "expects," "anticipates," "intends," "plans," "believes," "seeks," "estimates" and similar expressions are generally intended to identify forward-looking statements. Actual results may differ materially from the results discussed in these forward-looking statements, because such statements are inherently subject to significant assumptions, risks and uncertainties, many of which are difficult to predict and are generally beyond the Company's control. These include but are not limited to: the possibility of adverse economic developments that may, among other things, increase default and delinquency risks in the Company's loan portfolios; shifts in interest rates; shifts in the rate of inflation; shifts in the demand for the Company's loan and other products; unforeseen increases in costs and expenses; lower-than-expected revenue or cost savings in connection with acquisitions; changes in accounting policies; changes in the monetary and fiscal policies of the federal government; and changes in laws, regulations and the competitive environment. Unless legally required, the Company disclaims any obligation to update any forward-looking statements, whether as a result of new information, future events or otherwise.

SOURCE BANK OF SOUTH CAROLINA

© 2025 PR Newswire
Gewinner im Megamarkt
Biotechnologie ist eine der bedeutendsten Zukunftstechnologien unserer Zeit. Zahlreiche Biotechnologie- und Pharmakonzerne haben sich unter anderem dem Kampf gegen Tumorerkrankungen verschrieben. Der weltweite Markt für Krebsmedikamente verzeichnet ein stetiges Wachstum. Für das Jahr 2025 wird ein Umsatz von etwa 190,3 Milliarden Euro prognostiziert, mit einer erwarteten jährlichen Wachstumsrate von 6,42% bis 2029, was zu einem geschätzten Marktvolumen von 244,1 Milliarden Euro führen würde.

Wir haben 3 aussichtsreiche Biotechnologieaktien mit Schwerpunkt Erforschung und Entwicklung von Wirkstoffen gegen Tumorerkrankungen ausfindig gemacht, die in den kommenden Monaten und Jahren erhebliches Aufwärtspotenzial versprechen und Vervielfachungspotenzial besitzen.

Fordern Sie jetzt unseren neuen kostenlosen Spezialreport an und erfahren Sie, welche 3 Biotech-Aktien durchstarten und zu Ihrem Börsenerfolg in 2025 beitragen könnten!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.